Xbrane Biopharma AB Free Cash Flow Generation Index

Latest as of December 2024: 0.82x

Xbrane Biopharma AB free cash flow generation index. Xbrane Biopharma AB (XBRANE) has a Free Cash Flow Generation Index of 0.82x as of December 2024. Free cash flow of Skr76.61 Million represents 1% of operating cash flow (Skr93.91 Million).

FCF Generation Index

0.82x
Free Cash Flow / Operating CF

Free Cash Flow

Skr76.61 Million
SEK

Operating Cash Flow

Skr93.91 Million
SEK

Capital Expenditures

Skr17.30 Million
SEK

Free Cash Flow Generation Index of Xbrane Biopharma AB (2018–2018)

Free cash flow generation index of Xbrane Biopharma AB from 2018 to 2018. Historical FCF Generation Index trend for Xbrane Biopharma AB across 1 annual periods. See financial flexibility index of Xbrane Biopharma AB to measure the company's free cash flow as a share of total liabilities.

Xbrane Biopharma AB Free Cash Flow Generation Index by Year (2018–2018)

Xbrane Biopharma AB free cash flow generation index by year from 2018 to 2018. Year-by-year Free Cash Flow Generation Index for Xbrane Biopharma AB. For the full cash flow conversion analysis, see XBRANE cash flow conversion.

Year FCG Index Free Cash Flow (SEK) Operating CF Capital Expenditures YoY Change
2018 0.97x Skr45.11 Million Skr46.71 Million Skr1.60 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).